Inactive Instrument
NicOx SA Stock Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 32.65M 37.36M 30.13M 27.77M 52.35M 3.6B 53.51M 360M 142M 1.76B 140M 137M 6.07B | P/E 2026 * |
-5.29x | P/E 2027 * | 37.1x |
|---|---|---|---|---|---|
| Enterprise Value | 32.65M 37.36M 30.13M 27.77M 52.35M 3.6B 53.51M 360M 142M 1.76B 140M 137M 6.07B | EV / Sales 2026 * |
10.9x | EV / Sales 2027 * | 3.27x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 2024-02-27 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 2014-12-31 |
Doug Hubatsch
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 2024-04-07 |
Damian Marron
CHM | Chairman | 64 | 2024-07-15 |
Marc Bozec
BRD | Director/Board Member | - | 2024-07-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 37.36M | |
| -0.10% | +3.21% | +59.45% | +20.34% | 315B | |
| -1.20% | -2.43% | +23.24% | -8.55% | 67.81B | |
| +0.35% | +2.11% | +37.84% | +85.31% | 9.23B | |
| +0.34% | +0.51% | +5.21% | -1.87% | 8.56B | |
| +1.53% | -3.64% | -22.91% | -2.70% | 4.18B | |
| -11.03% | -12.07% | -8.02% | +16.19% | 3.59B | |
| +1.87% | +3.36% | -46.36% | +23.90% | 3.55B | |
| -0.35% | -0.87% | +48.55% | +58.44% | 2.79B | |
| -7.41% | -2.37% | +3.91% | -24.38% | 2.09B | |
| Average | -2.40% | -1.20% | +11.21% | +18.52% | 46.3B | |
| Weighted average by Cap. | -0.36% | +1.97% | +49.31% | +16.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3M 3.43M 2.77M 2.55M 4.81M 331M 4.92M 33.09M 13.01M 162M 12.89M 12.61M 557M | 10M 11.44M 9.23M 8.51M 16.03M 1.1B 16.39M 110M 43.38M 540M 42.97M 42.03M 1.86B |
| Net income | -6M -6.87M -5.54M -5.1M -9.62M -661M -9.83M -66.18M -26.03M -324M -25.78M -25.22M -1.11B | 1M 1.14M 923K 851K 1.6M 110M 1.64M 11.03M 4.34M 53.97M 4.3M 4.2M 186M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
